Yuanyuan Zeng
0000-0002-2260-4468
Publication & Citation Trends
Publications
244 total
CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer PDF
Cited by 98
OpenAlex
KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway PDF
Cited by 205
OpenAlex
Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer PDF
Cited by 158
OpenAlex
The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer PDF
Cited by 99
OpenAlex
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer PDF
Cited by 365
OpenAlex
CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer PDF
Cited by 96
OpenAlex
PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
Cited by 307
OpenAlex
Halide-Rich Synthesized Cesium Lead Bromide Perovskite Nanocrystals for Light-Emitting Diodes with Improved Performance
Cited by 297
OpenAlex
Research Topics
Cancer-related molecular mechanisms research
(23)
RNA modifications and cancer
(21)
MicroRNA in disease regulation
(20)
Lung Cancer Treatments and Mutations
(20)
Inflammatory mediators and NSAID effects
(19)
Affiliations
BGI Group (China)
Zhejiang International Studies University
Macau University of Science and Technology
Guangzhou University of Chinese Medicine
Fujian Medical University